Principal Financial Group
AVEO

Principal Financial Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Principal Financial Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,115
Closed -$25K – 2307
2019
Q1 		$25K Sell
3,115
-139
-4% -$1.44K ﹤0.01% 2196
2018
Q4 		$52K Sell
3,254
-561
-15% -$12.3K ﹤0.01% 2201
2018
Q3 		$126K Buy
3,815
+635
+20% +$16.3K ﹤0.01% 2217
2018
Q2 		$72K Buy
3,180
+1,119
+54% +$26.5K ﹤0.01% 2237
2018
Q1 		$60K Buy
2,061
+126
+7% +$3.69K ﹤0.01% 2174
2017
Q4 		$54K Buy
+1,935
New +$60.1K ﹤0.01% 2217

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Principal Financial Group's AVEO Position: Q2 2019 in Review

Principal Financial Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2019, closing a stake of 3,115 shares — an estimated $25K sold.

Principal Financial Group first reported a position in AVEO in Q4 2017 and held it in 6 quarters. The position peaked at $126K in Q3 2018. 73 funds tracked by Wall St. Rank hold AVEO as of Q2 2019.

  • Principal Financial Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Principal Financial Group sold 3,115 AVEO Pharmaceuticals, Inc. shares in Q2 2019, an estimated $25K.
  • Principal Financial Group first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 6 quarters.
  • Principal Financial Group's AVEO Pharmaceuticals, Inc. position peaked at $126K in Q3 2018.
  • 73 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2019.

Based on Principal Financial Group's 13F filing for Q2 2019, filed 12 Aug 2019.